Current concepts of surveillance and its significance in head and neck cancer

Annals of the Royal College of Surgeons of England

Volumn 93, Issue 8, 2011, Pages 576-582

  Manikantan, Kapila ^a,b   Dwivedi, Raghav C ^c   Sayed, Suhail I ^a,b   Pathak, K A ^d   Kazi, Rehan ^b,c  

^a GRANT MEDICAL COLLEGE   (India)

^b Cancer Aid and Research Foundation   (India)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Head and neck cancer; Recommendations; Surveillance

Indexed keywords

TUMOR MARKER;

AMBULATORY CARE; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; ECONOMICS; HEAD AND NECK TUMOR; HUMAN; LONG TERM CARE; METHODOLOGY; POSTOPERATIVE CARE; REVIEW; TUMOR RECURRENCE;

COST-BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; HEAD AND NECK NEOPLASMS; HUMANS; LONG-TERM CARE; NEOPLASM RECURRENCE, LOCAL; OFFICE VISITS; POSTOPERATIVE CARE; TUMOR MARKERS, BIOLOGICAL;

EID: 84555219752     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588411X604794     Document Type: Review

References (63)

1. Ridge JA. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 1993; 20: 419-429.
2. Schwartz LH, Ozsahin M, zhang GN et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74: 1,933-1,938.
3. Sturgis EM, Miller Rh. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995; 104: 946-954.
4. Vikram B, Strong EW, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984; 6: 734-737.
5. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet 1981; 2: 547-549.
6. de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994; 120: 934-939.
7. Johnson F, Johnson M, Virgo K. Current follow-up strategies after potentially curative resection of upper aerodigestive tract epidermoid carcinoma. Int J Oncol 1997; 10: 927-931.
8. Jones AS. Head and Neck Carcinoma: Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St Louis, MO: Mosby; 1997. pp65-71.
9. Loree TR. Head and Neck Carcinoma: Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St Louis, MO: Mosby; 1997. p72.
10. Schantz SP, Andersen PE. Head and Neck Carcinoma: Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St Louis, MO: Mosby; 1997. pp57-64.
11. Weymuller EA. Head and Neck Carcinoma: Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St Louis, MO: Mosby; 1997. pp72-75.
12. Austin JR. Carcinoma of the head and Neck. In: Berger Dh, Feig BW, Fuhrman GM, eds. The MD Anderson Surgical Oncology Handbook. Boston, MA: Little, Brown and Company; 1995.
13. Boysen M. Value of follow-up in patients treated for squamous cell carcinomas of the oral cavity and oropharynx. Recent Results Cancer Res 1994; 134: 205-214.
14. Coniglio JU, Netterville JL. Guidelines for Patient Management. In: Bailey BJ, Johnson JT, Pillsbury hC, Tardy ME, eds. Head and Neck Surgery - Otolaryngology. Philadelphia, PA: Lippincott Williams & Wilkins; 1993. pp1,021-1,028.
15. Marchant FE, Lowry LD, Moffitt JJ, Sabbagh R. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol 1993; 14: 88-93.
16. Boysen M, Lövdal O, Tausjö J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992; 28: 426-430.
17. Boysen M, Natvig K, Winther FO, Tausjö J. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck. J Otolaryngol 1985; 14: 211-214.
18. Byers RM. Head and Neck Cancer. In: Eiseman B, Robinson WA, Steele G, eds. Follow-up of the Cancer Patient. New York: Thieme; 1982. pp36-40.
19. Nakashima T. Head and Neck Carcinoma: Counterpoint. In: Johnson FE, Virgo KS, eds. Cancer Patient Follow-up. St Louis, MO: Mosby; 1997. pp64-65.
20. Yuen AP, Wei WI, Wong SH, ho WK. Comprehensive analysis of nodal recurrence of advanced laryngeal carcinoma following surgery. Eur J Surg Oncol 1996; 22: 350-353.
21. Lara PC, Cuyás JM. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 1995; 76: 758-764.
22. Engelen AM, Stalpers LJ, Manni JJ et al. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otorhinolaryngol 1992; 249: 364-369.
23. Söderholm AL, Lindqvist C, Haglund C. Tumour markers and radiological examinations in the follow-up of patients with oral cancer. J Craniomaxillofac Surg 1992; 20: 211-215.
24. Stalpers LJ, van Vierzen PB, Brouns JJ et al. The role of yearly chest radiography in the early detection of lung cancer following oral cancer. Int J Oral Maxillofac Surg 1989; 18: 99-103.
25. Head and Neck Cancers. In: Fischer DS, ed. Follow-up of Cancer: A Handbook for Physicians. 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins; 1996. pp8-25.
26. Medina JE. Clinical Practice Guidelines for the Diagnosis and Management of Cancer of the Head and Neck. Pittsburgh, PA: American Society for head and Neck Surgery, Society of head and Neck Surgeons; 1996.
27. British Association of head and Neck Oncologists. Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol 2001; 27 (Suppl A): S1-17.
28. Johnson FE, Virgo KS, Clemente MF et al. How tumor stage affects surgeons' surveillance strategies after surgery for carcinoma of the upper aerodigestive tract. Cancer 1998; 82: 1,932-1,937.
29. Flynn CJ, Khaouam N, Gardner S et al. The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer. Clin Oncol (R Coll Radiol) 2010; 22: 868-873.
30. Schwartz DL, Barker J, Chansky K et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma - too much for too little? Head Neck 2003; 25: 990-999.
31. Kissun D, Magennis P, Lowe D et al. Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic. Br J Oral Maxillofac Surg 2006; 44: 371-376.
32. Mukherji SK, Mancuso AA, Kotzur IM et al. Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology 1994; 193: 149-154.
33. Pameijer FA, Hermans R, Mancuso AA et al. Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure. Int J Radiat Oncol Biol Phys 1999; 45: 359-366.
34. O'Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 2003; 66: 323-326.
35. Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol 2003; 32: 107-109.
36. Ahuja A, Leung SF, Ying M, Metreweli C. Echography of metastatic nodes treated by radiotherapy. J Laryngol Otol 1999; 113: 993-998.
37. Hermans R, Pameijer FA, Mancuso AA et al. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology 2000; 214: 683-687.
38. Kostakoglu L, Goldsmith SJ. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 2004; 45: 56-68.
39. Schöder H, Yeung HW, Gonen M et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004; 231: 65-72.
40. Ong SC, Schöder H, Lee NY et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49: 532-540.
41. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008; 33: 210-222.
42. Abgral R, Querellou S, Potard G et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009; 50: 24-29.
43. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 1992; 101: 105-112.
44. Rachmat L, Vreeburg GC, de Vries N et al. The value of twice yearly bronchoscopy in the work-up and follow-up of patients with laryngeal cancer. Eur J Cancer 1993; 29A: 1,096-1,099.
45. Straka MB, Wagner RL, Johnson JT et al. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125. Arch Otolaryngol Head Neck Surg 1992; 118: 802-805.
46. Krimmel M, Hoffmann J, Krimmel C et al. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxillofac Surg 1998; 26: 243-248.
47. Zohar Y, Tovim RB, Laurian N, Laurian L. Thyroid function following radiation and surgical therapy in head and neck malignancy. Head Neck Surg 1984; 6: 948-952.
48. Cetinayak O, Akman F, Kentli S et al. Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 2008; 94: 19-23.
49. Garcia-Serra A, Amdur RJ, Morris CG et al. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 2005; 28: 255-258.
50. Virgo KS, Paniello RC, Johnson FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 1998; 124: 564-572.
51. Hsu YB, Chu PY, Liu JC et al. Role of chest computed tomography in head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134: 1,050-1,054.
52. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2008. Fort Washington, PA: NCCN; 2008.
53. Gordin A, Daitzchman M, Doweck I et al. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management. Laryngoscope 2006; 116: 273-278.
54. Johnson FE, Johnson MH, Clemente MF et al. Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol 2006; 13: 1,063-1,071.
55. Aich RK, Ranjan DA, Pal S et al. Iatrogenic hypothyroidism: a consequence of external beam radiotherapy to the head and neck malignancies. J Cancer Res Ther 2005; 1: 142-146.
56. Posttreatment surveillance of adults with squamous-cell carcinoma of the upper aerodigestive tract. Fr ORL 2005; 89: 128-135.
57. Guardiola E, Pivot X, Dassonville O et al. Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan? Cancer 2004; 101: 2,028-2,033.
58. Chao SS, Loh KS, Tan LK. Modalities of surveillance in treated nasopharyngeal cancer. Otolaryngol Head Neck Surg 2003; 129: 61-64.
59. Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg 1999; 125: 379-382.
60. Mercader VP, Gatenby RA, Mohr RM et al. CT surveillance of the thorax in patients with squamous cell carcinoma of the head and neck: a preliminary experience. J Comput Assist Tomogr 1997; 21: 412-417.
61. Misiti A, Macori F, Caimi M et al. Computerized tomography in the evaluation of the larynx after surgical treatment and irradiation. Radiol Med 1997; 94: 600-606.
62. Snyderman CH, D'Amico F, Wagner R, Eibling DE. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otolaryngol Head Neck Surg 1995; 121: 1,294-1,297.
63. Palmer BV, Gaggar N, Shaw hJ. Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx. Head Neck Surg 1981; 4: 13-15.